11/1
01:38 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.
11/1
12:49 pm
lmat
Rating for LMAT
Medium
Report
Rating for LMAT
11/1
12:49 pm
lmat
Rating for LMAT
Medium
Report
Rating for LMAT
11/1
11:29 am
lmat
Rating for LMAT
Medium
Report
Rating for LMAT
10/15
09:32 am
lmat
LeMaitre initiated with Neutral on valuation at Cantor Fitzgerald
Low
Report
LeMaitre initiated with Neutral on valuation at Cantor Fitzgerald
10/15
07:57 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) is now covered by analysts at Cantor Fitzgerald. They set a "neutral" rating and a $96.00 price target on the stock.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) is now covered by analysts at Cantor Fitzgerald. They set a "neutral" rating and a $96.00 price target on the stock.
10/15
07:21 am
lmat
Rating for LMAT
Low
Report
Rating for LMAT
10/15
06:11 am
lmat
LeMaitre initiated with neutral view at Cantor Fitzgerald
Low
Report
LeMaitre initiated with neutral view at Cantor Fitzgerald
9/20
11:27 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $92.00 price target on the stock.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $92.00 price target on the stock.
9/20
11:19 am
lmat
Rating for LMAT
Low
Report
Rating for LMAT